Product Information
ASENAPINE 10 MG TABLET SL is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $2.6272 per EA under NDC 51991036060. Its NADAC has been published 290 times since Mar 17, 2021.
FDA first approved this application on Dec 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991036060
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
ASENAPINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA205960FDA Approved
12/10/2020
TE Code
AB
On Market Since
12/10/2020
Pharmacological Classes
Price Statistics
The NADAC for ASENAPINE 10 MG TABLET SL has been published 290 times since Mar 17, 2021, and over the history we have for it it has declined 59.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6272 per EA |
|---|---|
| All-time high | $6.4971 (Apr 14, 2021) |
| All-time low | $1.8502 (Nov 20, 2024) |
| 52-week high | $2.9965 |
| 52-week low | $2.3634 |
| Median price | $2.9254 |
| Average price | $3.1787 |
| Largest weekly change | -32.5% (Nov 20, 2024) |
| Weeks tracked | 290 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ASENAPINE MALEATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Breckenridge Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ASENAPINE MALEATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ASENAPINE 10 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for ASENAPINE 10 MG TABLET SL, manufactured by Breckenridge Pharmaceutical Inc., is $2.6272 per EA (NDC 51991036060), effective Sep 30, 2026.
How has the price of ASENAPINE 10 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for ASENAPINE 10 MG TABLET SL has declined 59.6%. It has been tracked across 290 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for ASENAPINE 10 MG TABLET SL?
Since Mar 17, 2021, the NADAC for ASENAPINE 10 MG TABLET SL has ranged from a low of $1.8502 (Nov 20, 2024) to a high of $6.4971 (Apr 14, 2021), with a median of $2.9254 per EA.
Are there cheaper alternatives to ASENAPINE 10 MG TABLET SL?
No other NADAC-published product currently shares the active ingredient and strength of ASENAPINE 10 MG TABLET SL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ASENAPINE 10 MG TABLET SL?
ASENAPINE 10 MG TABLET SL (NDC 51991036060) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.